rxstat › Shortages › Erlotinib
Erlotinib shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Erlotinib products are in shortage in Canada (3 of 14 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jun 30, 2027.
In shortage since
Dec 1, 2020
Est. full return
Jun 30, 2027
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageNAT-ERLOTINIB
150MG · TABLET · NATCO PHARMA (CANADA) INC
DIN 02483939 · since Dec 1, 2020, est. end Jun 30, 2027 · Other (Please describe in comments)
Active shortageNAT-ERLOTINIB
100MG · TABLET · NATCO PHARMA (CANADA) INC
DIN 02483920 · since Dec 1, 2020, est. end Jun 30, 2027 · Other (Please describe in comments)
Active shortageNAT-ERLOTINIB
25MG · TABLET · NATCO PHARMA (CANADA) INC
DIN 02483912 · since Dec 1, 2020, est. end Jun 30, 2027 · Other (Please describe in comments)
ResolvedTEVA-ERLOTINIB
150MG · TABLET · TEVA CANADA LIMITED
DIN 02377713 · ended Mar 4, 2026 · Disruption of the manufacture of the drug.
DiscontinuedTARCEVA
25MG · TABLET · HOFFMANN-LA ROCHE LIMITED
DIN 02269007
DiscontinuedTARCEVA
100MG · TABLET · HOFFMANN-LA ROCHE LIMITED
DIN 02269015
DiscontinuedTARCEVA
150MG · TABLET · HOFFMANN-LA ROCHE LIMITED
DIN 02269023
ResolvedTEVA-ERLOTINIB
100MG · TABLET · TEVA CANADA LIMITED
DIN 02377705 · ended Aug 7, 2024 · Disruption of the manufacture of the drug.
ResolvedTEVA-ERLOTINIB
25MG · TABLET · TEVA CANADA LIMITED
DIN 02377691 · ended Jul 30, 2024 · Disruption of the manufacture of the drug.
ResolvedTEVA-ERLOTINIB
150MG · TABLET · TEVA CANADA LIMITED
DIN 02377713 · ended Apr 27, 2023 · Disruption of the manufacture of the drug.
DiscontinuedPMS-ERLOTINIB
150MG · TABLET · PHARMASCIENCE INC
DIN 02454394
DiscontinuedPMS-ERLOTINIB
100MG · TABLET · PHARMASCIENCE INC
DIN 02454386
Showing 12 of 19 reports. All reports are on file with Health Canada.
What's happening
Erlotinib is currently affected by 3 active shortage reports filed with Health Canada by NATCO PHARMA (CANADA) INC.
The reported cause is: other (please describe in comments). Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Erlotinib is classified under “OTHER ANTINEOPLASTIC AGENTS” (ATC L01XE).
Recent changes
Common questions
When will Erlotinib be back in stock in Canada?
The latest manufacturer estimate is Jun 30, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Erlotinib in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.